NKGEN BIOTECH INC (NKGN:OTCMKTS)

$0.06 0 (0%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 79

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed NKGEN BIOTECH INC (NKGN:OTCMKTS) News Sources

NKGen Biotech To Present on Allogeneic Enhanced NK Cells without Lymphodepletion in Solid Tumors at the 13th Annual Immuno-Oncology Summit

06-08-2025

yahoo.com

NKGen Biotech, Inc. Announces Completion of NKMax Co., Ltd. Acquisition; Gains Full Control of Global Manufacturing and Intellectual Property Assets

09-09-2025

yahoo.com

NKGen Biotech to Present on the Use of Troculeucel for Neurodegenerative Diseases at the 3rd China Great Bay Cell and Gene Therapy Forum

18-09-2025

yahoo.com

NKGen Biotech to Present on the Use of Troculeucel for Neurodegenerative Diseases at the XXVII World Congress of Neurology

06-10-2025

yahoo.com

NKGen Biotech Provides Clarification on Quotation Display and Trading Status on the OTC Expert Market

09-10-2025

yahoo.com

NKGen Biotech, Inc. Issues Statement on Recent Board Appointments at Majority-Owned Korean Affiliate NKGen Korea Co., Ltd.

03-12-2025

yahoo.com

NKGen Biotech Names Leading Dementia Expert Bruce L. Miller, M.D. to Scientific Advisory Board

22-01-2026

yahoo.com

NKGen Biotech Reports Combined Phase 1 Troculeucel Data Demonstrating Dose-Responsive Cognitive Improvements and Biomarker Correlations in Alzheimer’s Disease at AD/PD 2026™

23-03-2026

yahoo.com

NKGen Biotech to Present Troculeucel Mechanism Data in Alzheimer’s and Frontotemporal Dementia at the Neuroimmunology Drug Development Summit

09-04-2026

yahoo.com

NKGen Biotech Expands Clinical Trial Site Network for Alzheimer’s Disease Program Across U.S. to Improve Patient Access and Support Enrollment

19-05-2026

yahoo.com

NKGEN BIOTECH INC (NKGN:OTCMKTS) Sentiment Trend

0 25 50 75 100 87 71 77 78 76 74 82 74 85 84 06-08-2025 09-09-2025 18-09-2025 06-10-2025 09-10-2025 03-12-2025 22-01-2026 23-03-2026 09-04-2026 19-05-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

NKGEN BIOTECH INC (NKGN:OTCMKTS) FAQs

toggle

What is the current price of NKGEN BIOTECH INC (NKGN:OTCMKTS)?

The current price of NKGEN BIOTECH INC (NKGN:OTCMKTS) is $0.06.


toggle

NKGEN BIOTECH INC (NKGN:OTCMKTS) absolute price change since previous trading day?

The absolute price change of NKGEN BIOTECH INC (NKGN:OTCMKTS) since the previous trading day is $0.


toggle

NKGEN BIOTECH INC (NKGN:OTCMKTS) percentage price change since previous trading day?

The percentage price change of NKGEN BIOTECH INC (NKGN:OTCMKTS) since the previous trading day is 0%.


toggle

What is the most recent average sentiment score for NKGEN BIOTECH INC (NKGN:OTCMKTS)?

The most recent average sentiment score for NKGEN BIOTECH INC (NKGN:OTCMKTS) is 79 out of 100.


toggle

What is the most recent average sentiment for NKGEN BIOTECH INC (NKGN:OTCMKTS)?

The most recent sentiment for NKGEN BIOTECH INC (NKGN:OTCMKTS) is .


SEC-8K** Filing Available For NKGEN BIOTECH INC (NKGN:OTCMKTS)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.